Total Payments
$882,934
2024 Payments
$138,933
Companies
33
Transactions
471
Medicare Patients
2,237
Medicare Billing
$314,039
Payment Breakdown by Category
Consulting$477,643 (54.1%)
Other$290,462 (32.9%)
Travel$89,946 (10.2%)
Food & Beverage$12,820 (1.5%)
Research$12,063 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $477,643 | 140 | 54.1% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $201,312 | 53 | 22.8% |
| Travel and Lodging | $89,946 | 129 | 10.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $86,550 | 15 | 9.8% |
| Food and Beverage | $12,820 | 128 | 1.5% |
| Unspecified | $12,063 | 4 | 1.4% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $1,800 | 1 | 0.2% |
| Grant | $800.00 | 1 | 0.1% |
Payments by Type
General
$870,872
467 transactions
Research
$12,063
2 transactions
Ownership
$0
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bard Peripheral Vascular, Inc. | $325,813 | 106 | $0 (2024) |
| Biocompatibles, Inc. | $265,254 | 113 | $0 (2019) |
| Boston Scientific Corporation | $143,469 | 145 | $0 (2024) |
| Siemens Medical Solutions USA, Inc. | $30,918 | 16 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $25,812 | 16 | $0 (2024) |
| TriSalus Life Sciences, Inc. | $21,034 | 3 | $0 (2024) |
| Eisai Inc. | $13,878 | 4 | $0 (2024) |
| Varian Medical Systems, Inc. | $12,347 | 6 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $11,149 | 5 | $0 (2019) |
| AstraZeneca UK Limited | $7,370 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $138,933 | 70 | Bard Peripheral Vascular, Inc. ($64,418) |
| 2023 | $109,452 | 68 | Bard Peripheral Vascular, Inc. ($51,929) |
| 2022 | $92,038 | 60 | Bard Peripheral Vascular, Inc. ($45,791) |
| 2021 | $127,969 | 42 | Bard Peripheral Vascular, Inc. ($99,214) |
| 2020 | $68,660 | 32 | Bard Peripheral Vascular, Inc. ($35,972) |
| 2019 | $90,746 | 48 | Biocompatibles, Inc. ($62,243) |
| 2018 | $140,121 | 78 | Biocompatibles, Inc. ($114,959) |
| 2017 | $115,014 | 73 | Biocompatibles, Inc. ($88,053) |
All Payment Transactions
471 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| 12/17/2024 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,495.00 | General |
| 12/12/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $12,250.00 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 12/12/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,800.00 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 12/05/2024 | Boston Scientific Corporation | TheraSphere Administration Set (Device) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: TheraSphere Administration Set_PI | ||||||
| 12/03/2024 | TriSalus Life Sciences, Inc. | TRINAV INFUSION SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $20,000.00 | General |
| Category: ONCOLOGY | ||||||
| 11/22/2024 | Boston Scientific Corporation | TheraSphere Administration Set (Device) | Food and Beverage | In-kind items and services | $31.17 | General |
| Category: TheraSphere Administration Set_PI | ||||||
| 11/14/2024 | Delcath Systems | Hepzato Kit (Drug) | Consulting Fee | Cash or cash equivalent | $2,750.00 | General |
| Category: Oncology | ||||||
| 11/13/2024 | AstraZeneca UK Limited | — | Consulting Fee | Cash or cash equivalent | $5,370.00 | General |
| 11/12/2024 | Bard Peripheral Vascular, Inc. | — | Consulting Fee | Cash or cash equivalent | $812.50 | General |
| 11/12/2024 | Delcath Systems | Hepzato Kit (Drug) | Travel and Lodging | Cash or cash equivalent | $741.39 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Delcath Systems | Hepzato Kit (Drug) | Travel and Lodging | Cash or cash equivalent | $336.45 | General |
| Category: Oncology | ||||||
| 11/09/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $396.86 | General |
| Category: TheraSphere_PI | ||||||
| 11/08/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $601.80 | General |
| Category: TheraSphere_PI | ||||||
| 11/07/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 10 GBq (Device) | Food and Beverage | In-kind items and services | $191.95 | General |
| Category: TheraSphere_PI | ||||||
| 11/06/2024 | Penumbra, Inc. | Penumbra System (Device) | Food and Beverage | Cash or cash equivalent | $18.66 | General |
| Category: Neurointervention | ||||||
| 10/29/2024 | TriSalus Life Sciences, Inc. | TRINAV INFUSION SYSTEM (Device) | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| Category: ONCOLOGY | ||||||
| 10/22/2024 | Delcath Systems | HEPZATO KIT (Drug) | Food and Beverage | Cash or cash equivalent | $109.08 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Food and Beverage | In-kind items and services | $59.64 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 10/14/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Travel and Lodging | In-kind items and services | $410.49 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 10/14/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Travel and Lodging | In-kind items and services | $267.35 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 10/14/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Travel and Lodging | In-kind items and services | $199.30 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 10/14/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Food and Beverage | In-kind items and services | $143.83 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 10/14/2024 | Boston Scientific Corporation | TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) | Travel and Lodging | In-kind items and services | $100.00 | General |
| Category: TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial)_PI | ||||||
| 09/24/2024 | W. L. Gore & Associates, Inc. | GORE VIABIL Biliary Endoprosthesis (Device) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Devices | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| PROTEUS PROJECT | BARD PERIPHERAL VASCULAR, INC. | $9,438 | 1 |
| PROTEUS PROJECT | Bard Peripheral Vascular, Inc. | $2,625 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 653 | 992 | $883,898 | $83,080 |
| 2022 | 15 | 503 | 733 | $765,437 | $71,592 |
| 2021 | 14 | 582 | 886 | $881,815 | $81,254 |
| 2020 | 13 | 499 | 772 | $831,721 | $78,113 |
Total Patients
2,237
Total Services
3,383
Medicare Billing
$314,039
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 37243 | Occlusion of growths or obstructed vessels with review by radiologist | Facility | 2023 | 47 | 50 | $170,300 | $24,009 | 14.1% |
| 36247 | Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | Facility | 2023 | 58 | 99 | $385,407 | $19,264 | 5.0% |
| 75726 | Review by radiologist of abdominal artery image | Facility | 2023 | 53 | 102 | $30,192 | $8,233 | 27.3% |
| 75774 | Review by radiologist of additional artery image | Facility | 2023 | 51 | 165 | $19,800 | $6,507 | 32.9% |
| 36245 | Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | Facility | 2023 | 37 | 45 | $115,380 | $4,720 | 4.1% |
| 79445 | Radioactive drug therapy through a tube inserted in an artery | Facility | 2023 | 43 | 46 | $28,934 | $4,273 | 14.8% |
| 36248 | Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | Facility | 2023 | 48 | 99 | $49,500 | $4,149 | 8.4% |
| 36558 | Insertion of tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 16 | 17 | $31,161 | $3,716 | 11.9% |
| 76380 | Limited or follow-up ct scan | Facility | 2023 | 53 | 59 | $14,750 | $2,248 | 15.2% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 103 | 140 | $11,760 | $1,761 | 15.0% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 20 | 21 | $13,671 | $1,553 | 11.4% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 65 | 86 | $5,762 | $964.06 | 16.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 13 | 15 | $2,625 | $931.17 | 35.5% |
| 77001 | Fluoroscopic guidance for insertion or removal of central vein access device | Facility | 2023 | 46 | 48 | $4,656 | $749.76 | 16.1% |
| 37243 | Occlusion of growths or obstructed vessels with review by radiologist | Facility | 2022 | 47 | 51 | $173,706 | $24,658 | 14.2% |
| 36247 | Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | Facility | 2022 | 52 | 85 | $330,905 | $15,517 | 4.7% |
| 75726 | Review by radiologist of abdominal artery image | Facility | 2022 | 41 | 83 | $24,568 | $6,620 | 26.9% |
| 36558 | Insertion of tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 23 | 23 | $42,159 | $5,162 | 12.2% |
| 75774 | Review by radiologist of additional artery image | Facility | 2022 | 34 | 95 | $10,650 | $3,883 | 36.5% |
| 36245 | Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | Facility | 2022 | 28 | 36 | $92,304 | $3,843 | 4.2% |
| 36248 | Insertion of tube into abdominal, pelvic, or leg artery, additional second, third, and beyond | Facility | 2022 | 36 | 77 | $38,500 | $3,250 | 8.4% |
| 76380 | Limited or follow-up ct scan | Facility | 2022 | 35 | 49 | $12,250 | $1,929 | 15.7% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 93 | 119 | $9,996 | $1,405 | 14.1% |
| 79445 | Radioactive drug therapy through a tube inserted in an artery | Facility | 2022 | 14 | 14 | $8,806 | $1,300 | 14.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 15 | 16 | $2,800 | $1,092 | 39.0% |
About Dr. Robert Lewandowski, MD
Dr. Robert Lewandowski, MD is a Vascular & Interventional Radiology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689618761.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Lewandowski, MD has received a total of $882,934 in payments from pharmaceutical and medical device companies, with $138,933 received in 2024. These payments were reported across 471 transactions from 33 companies. The most common payment nature is "Consulting Fee" ($477,643).
As a Medicare-enrolled provider, Lewandowski has provided services to 2,237 Medicare beneficiaries, totaling 3,383 services with total Medicare billing of $314,039. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Vascular & Interventional Radiology
- Location Chicago, IL
- Active Since 06/16/2006
- Last Updated 07/08/2007
- Taxonomy Code 2085R0204X
- Entity Type Individual
- NPI Number 1689618761
Products in Payments
- THERASPHERE - BIO (Device) $251,883
- TheraSphere Y90 Glass Microspheres 10 GBq (Device) $40,043
- GENERAL - THERAPIES (Device) $21,063
- TRINAV INFUSION SYSTEM (Device) $21,034
- TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) (Device) $16,720
- IMFINZI (Biological) $16,487
- Lenvima (Drug) $13,878
- LC BEAD (Device) $13,213
- OPDIVO (Biological) $8,136
- GENERAL PAIN MANAGEMENT (Device) $8,000
- GENERAL THERAPIES (Device) $6,170
- General - Therapies (Device) $5,218
- GENERAL - IO ABLATION (Device) $4,750
- ANGIOJET (Device) $4,739
- GENERAL THERAPIES (Device) $4,108
- GENERAL IO ABLATION (Device) $4,000
- ONCOZENE (Device) $4,000
- INTERLOCK (Device) $3,830
- Hepzato Kit (Drug) $3,828
- GENERAL - EMBOLICS (Device) $2,600
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Vascular & Interventional Radiology Doctors in Chicago
Riad Salem, Md, MD
Vascular & Interventional Radiology — Payments: $2.4M
Vascular & Interventional Radiology $2.4M
Dr. Kush Desai, M.d, M.D
Vascular & Interventional Radiology — Payments: $1.0M
Vascular & Interventional Radiology $1.0M
Osmanuddin Ahmed, Md, MD
Vascular & Interventional Radiology — Payments: $660,213
Vascular & Interventional Radiology $660,213
Dr. Sreekumar Madassery, M.d, M.D
Vascular & Interventional Radiology — Payments: $515,261
Vascular & Interventional Radiology $515,261
Dr. Christopher Molvar, Md, MD
Vascular & Interventional Radiology — Payments: $506,500
Vascular & Interventional Radiology $506,500
Dr. Bulent Arslan, M.d, M.D
Vascular & Interventional Radiology — Payments: $330,674
Vascular & Interventional Radiology $330,674